Year 2001 | Year 2007 | Year 2011 | P value for trend | |
---|---|---|---|---|
n = 213 | n = 360 | n = 363 | ||
% | % | % | ||
Medications | ||||
Aspirin | 88.3 | 86.4 | 85.7 | 0.383 |
P2Y12-receptor inhibitors | 0 | 10.6 | 26.4 | <0.001 |
Anticoagulants | 85.4 | 92.8 | 95.0 | <0.001 |
Glycoprotein IIb/IIIa inh. | 0.5 | 3.1 | 5.2 | 0.003 |
Betablockers | 76.1 | 77.8 | 73.0 | 0.384 |
Nitrates | 96.7 | 85.6 | 78.8 | <0.001 |
ACEi/ARB | 37.1 | 62.2 | 55.9 | <0.001 |
Statins | 5.6 | 30.8 | 49.0 | <0.001 |
Cardiac catheterization | 0 | 6.7 | 18.5 | <0.001 |
Revascularization | 0 | 4.2 | 14.3 | <0.001 |
PCI | 0 | 4.2 | 14.3 | <0.001 |
CABG | 0 | 0 | 0 | - |
Echocardiography | 52.1 | 51.9 | 50.7 | 0.735 |
Referred to a tertiary care hospital | 5.8 | 24.8 | 40.1 | <0.001 |
Treatment for STEMI | n = 127 | n = 185 | n = 161 | |
Reperfusion for STEMI | 44.1 | 34.1 | 37.9 | 0.251 |
Thrombolysis | 44.1 | 34.1 | 29.2 | 0.008 |
Primary PCI | 0 | 0 | 8.7 | - |
Treatment for NSTEMI | n = 86 | n = 175 | n = 202 | |
PCI | 0 | 4.6 | 10.4 | 0.002 |
CABG | 0 | 0 | 0 | - |
Referred to a tertiary care hospital | 5.8 | 10.3 | 28.2 | <0.001 |